140 related articles for article (PubMed ID: 35802160)
1. Predicting response of micrometastases with MIRDcell V3: proof of principle with
Katugampola S; Wang J; Prasad A; Sofou S; Howell RW
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):3989-3999. PubMed ID: 35802160
[TBL] [Abstract][Full Text] [Related]
2. MIRD Pamphlet No. 27: MIRDcell V3, a Revised Software Tool for Multicellular Dosimetry and Bioeffect Modeling.
Katugampola S; Wang J; Rosen A; Howell RW;
J Nucl Med; 2022 Sep; 63(9):1441-1449. PubMed ID: 35145016
[TBL] [Abstract][Full Text] [Related]
3. MIRD pamphlet No. 25: MIRDcell V2.0 software tool for dosimetric analysis of biologic response of multicellular populations.
Vaziri B; Wu H; Dhawan AP; Du P; Howell RW;
J Nucl Med; 2014 Sep; 55(9):1557-64. PubMed ID: 25012457
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Evaluation of
Luna-Gutiérrez M; Cruz-Nova P; Jiménez-Mancilla N; Oros-Pantoja R; Lara-Almazán N; Santos-Cuevas C; Azorín-Vega E; Ocampo-García B; Ferro-Flores G
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569758
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo N-Particle (MCNP) Modeling of the Cellular Dosimetry of 64Cu: Comparison with MIRDcell S Values and Implications for Studies of Its Cytotoxic Effects.
Cai Z; Kwon YL; Reilly RM
J Nucl Med; 2017 Feb; 58(2):339-345. PubMed ID: 27660146
[TBL] [Abstract][Full Text] [Related]
6. Isolating effects of microscopic nonuniform distributions of (131)I on labeled and unlabeled cells.
Neti PV; Howell RW
J Nucl Med; 2004 Jun; 45(6):1050-8. PubMed ID: 15181140
[TBL] [Abstract][Full Text] [Related]
7. Liposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody.
Emfietzoglou D; Kostarelos K; Papakostas A; Yang WH; Ballangrud A; Song H; Sgouros G
J Nucl Med; 2005 Jan; 46(1):89-97. PubMed ID: 15632038
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of [
Cortez A; Josefsson A; McCarty G; Shtekler AE; Rao A; Austin Z; Nedrow JR
Nucl Med Biol; 2020; 88-89():62-72. PubMed ID: 32799049
[TBL] [Abstract][Full Text] [Related]
9. Transport-driven engineering of liposomes for delivery of α-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous metastases.
Prasad A; Nair R; Bhatavdekar O; Howe A; Salerno D; Sempkowski M; Josefsson A; Pacheco-Torres J; Bhujwalla ZM; Gabrielson KL; Sgouros G; Sofou S
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4246-4258. PubMed ID: 34117896
[TBL] [Abstract][Full Text] [Related]
10. Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression.
Ballangrud AM; Yang WH; Palm S; Enmon R; Borchardt PE; Pellegrini VA; McDevitt MR; Scheinberg DA; Sgouros G
Clin Cancer Res; 2004 Jul; 10(13):4489-97. PubMed ID: 15240541
[TBL] [Abstract][Full Text] [Related]
11. Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability.
Falzone N; Lee BQ; Able S; Malcolm J; Terry S; Alayed Y; Vallis KA
J Nucl Med; 2018 Jun; 60(2):250-8. PubMed ID: 29959216
[TBL] [Abstract][Full Text] [Related]
12. Carboxyfluorescein diacetate succinimidyl ester fluorescent dye for cell labeling.
Wang XQ; Duan XM; Liu LH; Fang YQ; Tan Y
Acta Biochim Biophys Sin (Shanghai); 2005 Jun; 37(6):379-85. PubMed ID: 15944752
[TBL] [Abstract][Full Text] [Related]
13. Alpha radioimmunotherapy using
Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM
Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220
[TBL] [Abstract][Full Text] [Related]
14. Engineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroids.
Kostarelos K; Emfietzoglou D; Papakostas A; Yang WH; Ballangrud AM; Sgouros G
J Liposome Res; 2005; 15(1-2):15-27. PubMed ID: 16194925
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of carboxyfluorescein diacetate and carboxyfluorescein diacetate succinimidyl ester as indicators of bacterial activity.
Hoefel D; Grooby WL; Monis PT; Andrews S; Saint CP
J Microbiol Methods; 2003 Mar; 52(3):379-88. PubMed ID: 12531507
[TBL] [Abstract][Full Text] [Related]
16. Remote-loading of liposomes with manganese-52 and in vivo evaluation of the stabilities of
Jensen AI; Severin GW; Hansen AE; Fliedner FP; Eliasen R; Parhamifar L; Kjær A; Andresen TL; Henriksen JR
J Control Release; 2018 Jan; 269():100-109. PubMed ID: 29122662
[TBL] [Abstract][Full Text] [Related]
17. Alpha-particle radiotherapy: For large solid tumors diffusion trumps targeting.
Zhu C; Sempkowski M; Holleran T; Linz T; Bertalan T; Josefsson A; Bruchertseifer F; Morgenstern A; Sofou S
Biomaterials; 2017 Jun; 130():67-75. PubMed ID: 28365545
[TBL] [Abstract][Full Text] [Related]
18. A GATE simulation study for dosimetry in cancer cell and micrometastasis from the
Koniar H; Miller C; Rahmim A; Schaffer P; Uribe C
EJNMMI Phys; 2023 Aug; 10(1):46. PubMed ID: 37525027
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
Essler M; Gärtner FC; Neff F; Blechert B; Senekowitsch-Schmidtke R; Bruchertseifer F; Morgenstern A; Seidl C
Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):602-12. PubMed ID: 22237842
[TBL] [Abstract][Full Text] [Related]
20. Engineered liposomes for potential alpha-particle therapy of metastatic cancer.
Sofou S; Thomas JL; Lin HY; McDevitt MR; Scheinberg DA; Sgouros G
J Nucl Med; 2004 Feb; 45(2):253-60. PubMed ID: 14960644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
